Vorinostat (SAHA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Vorinostat (SAHA), covering 2010-06-22 to 2010-06-22. Get the full timeline:
Most recent: Clinical Trial Update: Phase IIa Vorinostat (MK0683, Suberoylanilide Hydroxamic Acid (SAHA)) Study in Lower Risk Myelodysplastic Syndromes (0683-064) [Phase 2]